Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,414.80
(
1.37%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
99.38
(
-1.80%
)
Bitcoin
78,277.00
(
0.00%
)
News Focus
News Focus
Post# of 517559
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Steady_T

Send PM Follow Ignore
Followers 170
Posts 23056
Boards Moderated 1
Alias Born 12/09/2004

Steady_T

Member Level

Re: nidan7500 post# 176616

Saturday, 12/29/2018 1:43:15 PM

Saturday, December 29, 2018 1:43:15 PM

Post# of 517559
There was a slide set long ago that discussed the ERP and the improvements 2-73 made in normalizing the response curve in AD subjects.

That was a subject of considerable discussion back then.

What we are seeing now is the FDA approving the device that was being used by Anavex back then. Now we know how the data was taken and apparently by what device.

The important part is the FDA is accepting this as a marker for AD.

If investing was easy, everyone would be rich by now.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News